Buy these stocks in November and sell in December
Seasonality suggests November softness and December strength, yet select Pharma counters consistently outperform. Three stocks offering the favourable risk-reward from the pharma sector.
Seasonality suggests November softness and December strength, yet select Pharma counters consistently outperform. Three stocks offering the favourable risk-reward from the pharma sector.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
